Skip to main content

Table 3 Clinical and laboratory data and screening for chronic complications in the study population according to geographic region

From: Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group

 

Southeast

South

North/Northeast

Mid-west

P Value

N(%)

1,424(39.7)

820 (22.8)

1,113(31.0)

234 (6.5)

 

Glycemic Control

     

HbA1c

 

Frequency of Complete Records n (%)

1,356 (95.2)

809 (98.7)

978(87.9)

210 (89.7)

<0.001

Mean (SD)

9.1 ± 2.3

9.4 ± 2.1#

9.4 ± 2.6#

9.1 ± 2.6

0.002

Patients at Goal

276 (20.6)

98 (12.2)*

154 (20.4)

42 (21.4)

<0.001

FPG

 

Frequency of Complete Records n (%)

1,251 (87.9)

803 (97.9)

1,016 (91.3)

187 (79.9)

 

Mean (SD)

187.3 (108.4)#

174.4 (94.4)

185.3 ± 108.2#

179.0 ± 102.60

<0.001

Patients at Goal

332 (26.6)

293 (36.5)

301 (29.6)

53 (28.3)

<0.001

Cardiovascular Risk Factors

     

BMI

1,419 (99.6)

819 (99.9)

1,104 (99.2)

226 (96.6)

 

Frequency of Complete Records n (%)

 

Mean (SD)

21.9 ± 4.4

22.2 ±3.3*

20.9 ± 4.2

21.7 ± 4.6

0.01

Patients at Goal

942 (66.4)

547 (66.8)

823 (74.5)*

150 (66.4)

0.009

sBP

     

Frequency of Complete Records n (%)

1,393 (97.8)

811 (98.9)

1,040 (93.4)

193 (82.5)

 

Mean (SD)

111.4 ± 16.0

111.7 ± 17.9

109.1 ± 17.4*

115.8 (19.3)

<0.001

Patients at Goal

1,159 (83.2)

667 (82.2)

893 (85.9)

148 (76.7)

0.009

dBP

     

Frequency of Complete Records n (%)

1,392 (97.8)

811 (98.9)

1,032 (92.7)

191 (81.6)

 

Mean (SD) mmHg

71.4 ± 11.02

71.4 ± 11.7

70.9 ± 12.2

71.8 ± 12.2

0.31

Patients at Goal

890 (63.9)

523 (64.5)

709 (68.7)

137 (71.7)*

0.003

Triglycerides (mg/dl)

     

Frequency of Complete Records n (%)

1,262 (88.6)

496 (60.5)

853 (76.6)

181 (77.4)

 

Mean (SD)

87.7 ± 69.1

95.3 ± 72.1

103.5 ± 76.9

91.6 ± 58.1

0.006

Patients at Goal

986 (78.1)

407 (82.1)

589 (69.1)*

145 (80.1)

0.001

HDL (Cholesterol)

     

Frequency of Complete Records n (%)

1,227 (86.2)

487 (59.4)

838 (75.3)

180 (76.9)

 

Mean (SD)

53.3 ± 14.8*

53.9 ± 15.2***

50.1 ± 14.1

52.0 ± 12.1

0.01

Patients at Goal n (%)

984 (80.2)****

369 (75.8)

604 (72.1)

141 (78.3)

0.004

LDL Cholesterol

     

Frequency of Complete Records n (%)

1,218 (85.5)

483 (58.9)

821 (73.8)

179 (76.5)

 

Mean (SD)

96.9 ± 33.1***

102.6 ± 31.3

102.9 ± 35.7

102.1 ± 28.3

<0.002

Patients at Goal n (%)

730 (59.9)*

241 (49.9)

422 (51.4)

89 (49.7)

<0.001

Non-HDL Cholesterol

1,227 (86.2)

487(59.4)

835 (75)

180 (76.9)

 

Frequency of Complete Records n (%)

     

Mean (SD)

113.7 ± 39.1 ###

121.6 ± 37.5*

122.0 ± 43.1*

119.5 ± 32.7

0.001

Patients at Goal

924 (75.3)****

322 (66.1)

529 (63.4)

123 (68.3)

<0.001

Smoking Status (y), N (%)

56 (4.1)

60 (7.5)

24 (2.2)

10 (4.5)

0.000

Chronic Complications

     

Feet examination

 

Yes, n(%)

1,071 (75.2)*

465 (56.7)

588 (52.8)

128 (54.7)

<0.001

Fundoscopy y, n(%)

 

Yes,n (%)

714 (50.1)+

462 (56.3)*

427 (38.4)

80 (34.2)

<0.001

Urine Albumin

 

Yes, n (%)

661 (46.4)+

484 (59)*

361 (32.4)

72 (30.8)

<0.001

  1. Data are presented as the means (SD) and n (%); y = yes * P<0.001 vs. each other region; *** p<0.002 vs. each other region; **** p<0.01 vs. each other region; ### p<0.005 vs. each other region; + p<0.01 vs. north/northeast and mid–west regions For comparison between continuous variables ANOVA with Sidak correction were used; For comparison between discrete variables two-sided z-tests with correction was used.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us